RE:RE:RE:RE:Could Theralase rise like ICCM today? plantrader wrote: N0taP00p wrote: I'm hoping it's just a lack of exposure to mainstream business media sources and nothing else. Even then a BT designation, insider buying and high CR numbers somehow don't seem to move the needle.
N0ta, Maybe the aspect that the founder was sanctioned by the OSC plays a role with bigger investors being hesitant? Their market cap seems so low vs their reported clinical progress. But we know the FDA can validate them and provide blatant credibility in one fell swoop by granting BTD/AA. Suddenly big investors will have amnesia about the past and will start loading up.
plantrader, It could be the under-treatment issue and waiting to see how the FDA reacts to that in the broader context. All in all, would be nice to have a mega booster NR in January. I'm keeping my hopes bottled up for now while desperately channeling my inner Eckhart Tolle for a $20 stock price next year. Very conflicted way to live life, eh?